313TiPOpen-label phase II study of everolimus plus endocrine therapy in post-menopausal women with ER+, HER2- metastatic breast cancer (Chloe trial). (18th September 2017) - Shien, T.; Shimomura, A.; Uemura, Y.; Kato, H.; Kitada, M.; Kikawa, Y.; Shiba, E.; Yoshida, T.; Morimoto, T.; Toyama, T.; Aihara, T.; Mukai, H.